Haemonetics · 22 hours ago
Accounting Intern
Boston, MA, US
Internship
Hybrid
Intern
$20.63/hr - $27.85/hr
Start in 2026 SummerHaemonetics is a company that provides blood management solutions through a comprehensive portfolio of devices and services. The Accounting Intern will work on projects to improve accounting processes, including identifying gaps and implementing changes for efficiency.
BiotechnologyConsultingHealth CareMedicalMedical Device
Responsibilities
Reviewing and mapping out current processes in order to identify and execute improvements
Gathering and transforming data to ensure completeness and accuracy. Business users will be able to search for, build better analytics, etc. off of the data
Maintaining and streamlining the controls environment for the next fiscal year within our audit, compliance & risk management software
Using standardized template and refresh and update all existing policies
Qualification
Required
Education: B.S. or M.S. in Accounting or Finance – Required
Technical Skills: MS Office such as Word, Outlook, Excel (e.g. vlookups)
Benefits
401(k) with up to a 6% employer match and no vesting period
An employee stock purchase plan
Flexible time off for salaried employees
For hourly employees, accrual of three to five weeks’ vacation annually (based on tenure)
Accrual of up to 64 hours (annually) of paid sick time
Paid and/or floating holidays
Parental leave
Short- and long-term disability insurance
Tuition reimbursement
Health and welfare benefits
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
Founded in 1971
1001-5000 employees
H1B Sponsorship
Haemonetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (3)
2022 (2)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Christopher Simon
President and Chief Executive Officer
Christopher Lindop
CFO and VP Business Development
Recent News
2026-01-03
2025-12-02
2025-11-21
Company data provided by crunchbase